New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
15:21 EDTPLL, LTD, BOOM, MYL, JCP, CSGP, WES, MNST, GRPN, ANWCompanies reporting After the Market Close on Wednesday, February 27
Notable companies reporting after the closing bell on Wednesday include Aegean Marine Petroleum Network (ANW), CoStar Group (CSGP), Dynamic Materials (BOOM), Groupon (GRPN), J C Penney (JCP), Limited Brands (LTD), Monster Beverage (MNST), Mylan (MYL), Pall (PLL), and Western Gas Partners (WES).
News For ANW;CSGP;BOOM;GRPN;JCP;LTD;MNST;MYL;PLL;WES From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 20, 2015
12:56 EDTMYLMylan says continues to believe '808 patent is 'invalid'
Subscribe for More Information
10:40 EDTMYLMomenta Pharma sinks after Supreme Court rules on Copaxone
Subscribe for More Information
06:22 EDTJCPJ.C. Penney to bring back 120-page catalog, WSJ reports
J.C. Penney has decided to resurrect its catalog in the form of a 120-page book that will mark the first catalog the chain has sent out since 2010, The Wall Street Journal reports. The retailer, which quit the catalog amid a broader pullback caused by the recession and the rise of e-commerce, now believes the catalog can help drive web sales. Reference Link
January 15, 2015
14:31 EDTMYLMylan launches generic Epivir-HBV tablets
Mylan (MYL) announced the U.S. launch of its Lamivudine Tablets, 100 mg, which is the generic version of GlaxoSmithKline's (GSK) Epivir-HBV. Mylan received final approval from the U.S. FDA for its Abbreviated New Drug Application for this product, which is indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. Lamivudine Tablets, 100 mg, had U.S. sales of approximately $18.1M for the 12 months ending September 30, 2014, according to IMS Health. Currently, Mylan has 284 ANDAs pending FDA approval representing $109.1B in annual brand sales, according to IMS Health. Forty-four of these pending ANDAs are potential first-to-file opportunities, representing $29.3B in annual brand sales, for the 12 months ending June 30, 2014, according to IMS Health.
10:37 EDTMNSTKraft rises after Goldman gets less cautious on food space, ups stock to buy
Shares of Kraft Foods (KRFT) are climbing after Goldman Sachs upgraded the stock to Buy and placed the shares on its Conviction List. WHAT'S NEW: Costs for food makers are declining as commodity prices drop, Goldman Sachs analyst Judy Hong wrote in a note to investors today. Kraft is among the U.S. food companies that benefits the most from lower costs, the analyst stated. Additionally, Kraft's pricing power is one of the strongest in the group and it is heavily exposed to the U.S. economy, the analyst stated. WHAT'S NOTABLE: Hong's upgrade of Kraft was part of a note in which she took a more balanced view of the U.S. consumer staples sector. The analyst upgraded the Food sector to Neutral from Cautious, noting that consumer staples stocks with outsized exposure to the U.S. market should be boosted by strong U.S. growth and more favorable foreign exchange dynamics than their peers. In addition to Kraft, the analyst identified the following stocks as her top picks within the consumer staples sector: Monster Beverage (MNST), Constellation Brands (STZ), Coca-Cola Enterprises (CCE), Keurig Green Mountain (GMCR), Freshpet (FRPT), Mead Johnson (MJN), and Estee Lauder (EL). Goldman also upgraded Hershey (HSY), Dr. Pepper Snapple (DPS), and Clorox (CLX), all to Neutral from Sell, downgraded cigarette maker Philip Morris (PM) to Sell from Neutral and downgraded brewer Molson Coors (TAP) to Neutral from Buy. PRICE ACTION: In early trading, Kraft climbed 3.7% to $65 per share.
10:29 EDTGRPNOptions with increasing implied volatility
Subscribe for More Information
08:08 EDTGRPNGroupon upgraded at Evercore ISI
Subscribe for More Information
06:15 EDTGRPNGroupon upgraded to Hold from Sell at Evercore ISI
Subscribe for More Information
January 14, 2015
10:39 EDTGRPNOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTMNSTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:50 EDTMNSTMonster Beverage upgraded to Outperform at Cowen
Subscribe for More Information
06:50 EDTMNSTMonster Beverage upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
January 13, 2015
10:17 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
10:16 EDTMNSTMonster Beverage rises as Stifel target hike outweighs Wells Fargo downgrade
Subscribe for More Information
10:00 EDTMNSTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:23 EDTMNSTMonster Beverage volatility elevated into investor meeting
Monster Beverage January call option implied volatility is at 49, February is at 34, March is at 36; compared to its 26-week average of 30 according to Track Data, suggesting larger near term price movement into a company hosted investor meeting today.
07:41 EDTMNSTWells downgrades Monster Beverage on valuation
Subscribe for More Information
07:13 EDTMNSTMonster Beverage price target raised to $130 from $115 at Stifel
Subscribe for More Information
05:51 EDTMNSTMonster Beverage downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
05:50 EDTGRPNStocks with implied volatility movement; GRPN FEYE
Stocks with implied volatility movement; Groupon (GRPN) 70, FireEye (FEYE) 66 according to iVolatility.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use